Effects of Mifepristone on the Growth and Metastasis of Human Gastric Cancer in Vivo and in Vitro

李大强,王智彪,白晋,赵颉,王媛,胡凯

DOI: https://doi.org/10.3760/j.issn:1001-9030.2003.09.004

2003-01-01

Abstract:Objective To explore the effects of mifepristone (MIF) on the growth and metastasis of the SGC-7901 human gastric cancer cells in vivo and in vitro.Methods The expression of progestin receptor (PR) in SGC-7901 cells was detected by using in situ hybridization assay.A membrane invasion culture system,Transwell Insert,was used to analyze the migrative potential of the cells.SGC-7901 cells were subcutaneously xenografted in nude mice.Mifepristone was administrated for 6 weeks at a dose of 50 mg/kg daily to explore its effects on the tumor growth and metastasis,and the expression of microvessel density (MVD),vascular endothelial growth factor (VEGF),proliferating cell nuclear antigen (PCNA) and Caspase-3 detected by immunohistochemical staining.Results PR mRNA was highly expressed in the SGC-7901 cells.After treatment for 24 h with 20 μmol/L MIF,the number of the migrated SGC-7901 cells (56±5) was significantly deceased as compared with control group (104±12,P0.01).MIF could markedly inhibit the tumor growth with the inhibitory rate being 41.15 %.Lung metastasis was seen in 3 mice of control group but in only one mice of the MIF-treated group.In addition,MIF could down-regulate the expression of MVD,VEGF and PCNA,whereas up-regulate the expression of Caspase-3 in gastric cancer tissue.Conclusion MIF can effectively inhibit the growth and metastasis of gastric cancer cells in vitro and in vivo,which may be related with the decrease of tumor cell proliferation,migration and angiogenesis,and the simultaneous increase of tumor apoptosis.